Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers
Curcumin is poorly absorbed, which is interest in new preparations. However, little is known about variations in its pharmacokinetics and tissue bioavailability between formulations. In this randomized, crossover study we evaluated the relationship between steady-state plasma and rectal tissue curcu...
Saved in:
Published in | Journal of clinical pharmacology Vol. 57; no. 2; p. 185 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.02.2017
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Curcumin is poorly absorbed, which is interest in new preparations. However, little is known about variations in its pharmacokinetics and tissue bioavailability between formulations. In this randomized, crossover study we evaluated the relationship between steady-state plasma and rectal tissue curcuminoid concentrations using standard and phosphatidylcholine curcumin extracts. There was no difference in the geometric mean plasma AUCs when adjusted for the 10-fold difference in curcumin dose between the 2 formulations. Phosphatidylcholine curcumin extract yielded only 20% to 30% plasma demethoxycurcumin and bisdemethoxycurcumin conjugates compared to standard extract, yet yielded 20-fold greater hexahydrocurcumin. When adjusting for curcumin dose, tissue curcumin concentrations were 5-fold greater for the phosphatidylcholine extract. Improvements in curcuminoid absorption due to phosphatidylcholine are not uniform across the curcuminoids. Furthermore, curcuminoid exposures in the intestinal mucosa are most likely due to luminal exposure rather than to plasma disposition. Finally, once-daily dosing is sufficient to maintain detectable curcuminoids at steady state in both plasma and rectal tissues. |
---|---|
AbstractList | Curcumin is poorly absorbed, which is interest in new preparations. However, little is known about variations in its pharmacokinetics and tissue bioavailability between formulations. In this randomized, crossover study we evaluated the relationship between steady-state plasma and rectal tissue curcuminoid concentrations using standard and phosphatidylcholine curcumin extracts. There was no difference in the geometric mean plasma AUCs when adjusted for the 10-fold difference in curcumin dose between the 2 formulations. Phosphatidylcholine curcumin extract yielded only 20% to 30% plasma demethoxycurcumin and bisdemethoxycurcumin conjugates compared to standard extract, yet yielded 20-fold greater hexahydrocurcumin. When adjusting for curcumin dose, tissue curcumin concentrations were 5-fold greater for the phosphatidylcholine extract. Improvements in curcuminoid absorption due to phosphatidylcholine are not uniform across the curcuminoids. Furthermore, curcuminoid exposures in the intestinal mucosa are most likely due to luminal exposure rather than to plasma disposition. Finally, once-daily dosing is sufficient to maintain detectable curcuminoids at steady state in both plasma and rectal tissues. |
Author | Sandler, Robert S Dossou, Katina S S Xie, Ying Asher, Gary N Moaddel, Ruin Hawke, Roy L Kashuba, Angela D M Sanghvi, Mitesh |
Author_xml | – sequence: 1 givenname: Gary N surname: Asher fullname: Asher, Gary N organization: Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA – sequence: 2 givenname: Ying surname: Xie fullname: Xie, Ying organization: State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau – sequence: 3 givenname: Ruin surname: Moaddel fullname: Moaddel, Ruin organization: Laboratory of Clinical Investigation, Division of Intramural Research Programs, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA – sequence: 4 givenname: Mitesh surname: Sanghvi fullname: Sanghvi, Mitesh organization: Laboratory of Clinical Investigation, Division of Intramural Research Programs, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA – sequence: 5 givenname: Katina S S surname: Dossou fullname: Dossou, Katina S S organization: Laboratory of Clinical Investigation, Division of Intramural Research Programs, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA – sequence: 6 givenname: Angela D M surname: Kashuba fullname: Kashuba, Angela D M organization: Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA – sequence: 7 givenname: Robert S surname: Sandler fullname: Sandler, Robert S organization: Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA – sequence: 8 givenname: Roy L surname: Hawke fullname: Hawke, Roy L organization: Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27503249$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kM1KAzEUhYMo9kfBJ5C8QGtyO39dyqBWKFhqdVvuJHds6iQZkhmhrn1wK-rq8J3FB-eM2Knzjhi7kmIqhYCbvWp300JkJ2wo0xQmSSaSARvFuBdCZkkqz9kA8lTMIJkP2dcanfbWfJLmqx0Gi8q_G0edUbwMPkb_QYE_d70-8NLbFoNxbxx42QfVW-P4KtCxxM54F_kPNxgt8qOVr0l12PCNibEn7mu-IGy63YEveouOv_qmdx1RiBfsrMYm0uVfjtnL_d2mXEyWTw-P5e1yopJCZhOsYaalklALgFrNtK4pL2QNGhMhBeJxkdY5VVmWV1RIJAUgsAIgPYdKwJhd_3rbvrKkt20wFsNh-38HfAP46mPp |
CitedBy_id | crossref_primary_10_1080_17425255_2017_1360279 crossref_primary_10_1097_NT_0000000000000392 crossref_primary_10_1002_ptr_7190 crossref_primary_10_1007_s11356_022_20137_w crossref_primary_10_1186_s12906_019_2699_x crossref_primary_10_1021_acsomega_2c07326 crossref_primary_10_1097_PPO_0000000000000403 crossref_primary_10_3390_nu11092147 crossref_primary_10_1016_j_dmpk_2017_10_005 crossref_primary_10_1080_07315724_2017_1358118 crossref_primary_10_1002_ptr_5931 crossref_primary_10_3390_molecules25061397 crossref_primary_10_1016_j_cis_2021_102582 crossref_primary_10_1080_1028415X_2020_1760531 crossref_primary_10_3390_molecules21101401 crossref_primary_10_1021_acsptsci_2c00012 crossref_primary_10_1208_s12248_016_0003_2 crossref_primary_10_1002_biof_1452 crossref_primary_10_1002_jcp_29464 crossref_primary_10_1111_cts_13250 crossref_primary_10_1016_j_jff_2022_105396 crossref_primary_10_1021_acsami_3c05560 crossref_primary_10_3390_nu13051519 crossref_primary_10_1002_jcp_29580 crossref_primary_10_1002_mnfr_202100613 crossref_primary_10_1615_CritRevOncog_2023045587 crossref_primary_10_1016_j_ejphar_2022_175321 crossref_primary_10_1002_ptr_7264 crossref_primary_10_1093_jnen_nlac034 crossref_primary_10_1093_jpp_rgab028 crossref_primary_10_1002_mnfr_202200798 crossref_primary_10_3390_pharmaceutics15041275 crossref_primary_10_3390_antiox10111826 |
ContentType | Journal Article |
Copyright | 2016, The American College of Clinical Pharmacology. |
Copyright_xml | – notice: 2016, The American College of Clinical Pharmacology. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/jcph.806 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1552-4604 |
ExternalDocumentID | 27503249 |
Genre | Research Support, N.I.H., Intramural Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: P30 DK034987 – fundername: NCI NIH HHS grantid: P50 CA106991 – fundername: NCCIH NIH HHS grantid: R21 AT003892 – fundername: NCATS NIH HHS grantid: KL2 TR000084 |
GroupedDBID | --- .55 .GJ 05W 0R~ 123 18M 1CY 1OB 1OC 29K 33P 34G 39C 3O- 3SF 4.4 52U 52V 53G 5RE 8-1 A00 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAYOK AAZKR ABCUV ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACXBN ACXME ACXQS ADBBV ADBTR ADEOM ADIZJ ADMGS ADOZA ADXAS AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AHBTC AHMBA AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUVAJ AVWKF AZFZN AZVAB BDRZF BFHJK BHBCM BMXJE BOGZA BRXPI C45 CAG CGR COF CS3 CUY CVF D-I DCZOG DPXWK DRFUL DRMAN DRSTM DU5 EBD EBS ECM EIF EJD EMOBN F5P FEDTE FUBAC G-S GODZA GWYGA H13 HF~ HGLYW HVGLF IAO IEA IHR INH INR IVC KBYEO LATKE LEEKS LH4 LOXES LSO LUTES LW6 LYRES M4V MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NPM O66 O9- OVD P2P P2W PALCI PQQKQ R.K RIWAO RJQFR ROL SAMSI SUPJJ SV3 TEORI VH1 WBKPD WH7 WIH WIJ WIK WOHZO WOIKV WPGGZ WXSBR WYJ X7M YCJ ZGI ZXP ZZTAW |
ID | FETCH-LOGICAL-c4816-af23d1c12f022fc3ddfe781f2da4010aa249dd7eb667be81aec220ab22ed92b02 |
IngestDate | Tue Aug 27 13:49:04 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | clinical trial steady state pharmacokinetics human curcumin |
Language | English |
License | 2016, The American College of Clinical Pharmacology. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4816-af23d1c12f022fc3ddfe781f2da4010aa249dd7eb667be81aec220ab22ed92b02 |
OpenAccessLink | https://europepmc.org/articles/pmc5233601?pdf=render |
PMID | 27503249 |
ParticipantIDs | pubmed_primary_27503249 |
PublicationCentury | 2000 |
PublicationDate | February 2017 |
PublicationDateYYYYMMDD | 2017-02-01 |
PublicationDate_xml | – month: 02 year: 2017 text: February 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of clinical pharmacology |
PublicationTitleAlternate | J Clin Pharmacol |
PublicationYear | 2017 |
References | 21413691 - J Nat Prod. 2011 Apr 25;74(4):664-9 18559556 - Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1411-7 17522064 - Carcinogenesis. 2007 Aug;28(8):1765-73 25500488 - Int J Clin Pharmacol Ther. 2015 Jan;53(1):54-65 23233733 - Cancer Prev Res (Phila). 2013 Feb;6(2):119-28 26943947 - Epilepsy Behav. 2016 Apr;57(Pt A):105-10 25250612 - Int J Clin Pharmacol Ther. 2014 Nov;52(11):965-72 21532153 - Biol Pharm Bull. 2011;34(5):660-5 16545122 - BMC Complement Altern Med. 2006 Mar 17;6:10 16172212 - Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2076-81 25840923 - Dig Dis Sci. 2015 Apr;60(4):1052-8 23594449 - Altern Ther Health Med. 2013 Mar-Apr;19(2):20-2 12454832 - Gastroenterology. 2002 Dec;123(6):1770-7 18462866 - Cancer Lett. 2008 Aug 18;267(1):133-64 21603867 - Cancer Chemother Pharmacol. 2012 Jan;69(1):65-70 19803548 - Altern Med Rev. 2009 Sep;14(3):226-46 16448179 - J Agric Food Chem. 2006 Feb 8;54(3):756-64 17051370 - Cancer Chemother Pharmacol. 2007 Jul;60(2):171-7 15668484 - Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):120-5 17227090 - J Agric Food Chem. 2007 Jan 24;55(2):538-44 22996406 - Biofactors. 2013 Jan-Feb;39(1):14-20 |
References_xml | |
SSID | ssj0016451 |
Score | 2.4038162 |
Snippet | Curcumin is poorly absorbed, which is interest in new preparations. However, little is known about variations in its pharmacokinetics and tissue... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 185 |
SubjectTerms | Adolescent Adult Aged Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - classification Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics Area Under Curve Biological Availability Biotransformation Cross-Over Studies Curcumin - administration & dosage Curcumin - analogs & derivatives Curcumin - classification Curcumin - metabolism Curcumin - pharmacokinetics Female Glucuronides Healthy Volunteers Humans Intestinal Absorption Male Middle Aged Rectum - metabolism Young Adult |
Title | Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27503249 |
Volume | 57 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6l9MIFFVoeLaA5oF6oiz2x1_axioAKiSoqaRVO1dq7SwKKE7VJpfbMP-GPMvvwQ6GIx8WKvYrl7PdlPDs78w1jr7RSSmdcBuRdYBAL0Q8EchHEmSBnJE3zxLZ7-3jCj8_iD-Nk3Ov96GQtrZbFYXl7Z13J_6BK1whXUyX7D8g2N6UL9JnwpSMhTMe_wvhUVHI-m96S0zj0EtTfyGs0GqwD8_Yz6Zk2U9D_722uHb4erC7L1WxamfwLJ_3t08mH5ErPhK9ZLE2Z5MjiYqP9NlHsxkf9z-l3ESQ-ff4O77apuFy02thN9P6obrf-3uTsNZtBY7dX8rl-m9pcYGMZbZj6dDVtiPxJVF8m11OX90_O8qQbvKAXYtgkgihvcBOiCHctiGuL7CSrPfOwY14j197nF7PvZGS_lovJYWYFDJYd9BczC78RsifvMf_z6JoAdz20wTbSzJjSExMQ8htVPE6iWtM4xDf1IxiNaf-1tfWK9VtGW-yBhwSOHHsesp6qHrF9T5ebAxi1BXhXB7APww5e2-x7SzFYoxg0FANLMWgoBgg1xaBLMTDnlmJAdwVHMXAUg7kGTzGwFIOWYjvs7N3b0eA48I07gjLOIh4IjX0ZlRFq8hB12ZdSqzSLNEpBy_lQCJoWKU03Hp4WKouEKhFDUSAqmWMR4mN2r5pX6imDFFVYSBkXHCNaOyRFKnKuUrN9LXI6e8aeuNm9WDh1lot63nd_O7LH7rdcfM42NZkD9YJ8y2Xx0qL7Exw1gd4 |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Randomized+Pharmacokinetic+Crossover+Study+Comparing+2+Curcumin+Preparations+in+Plasma+and+Rectal+Tissue+of+Healthy+Human+Volunteers&rft.jtitle=Journal+of+clinical+pharmacology&rft.au=Asher%2C+Gary+N&rft.au=Xie%2C+Ying&rft.au=Moaddel%2C+Ruin&rft.au=Sanghvi%2C+Mitesh&rft.date=2017-02-01&rft.eissn=1552-4604&rft.volume=57&rft.issue=2&rft.spage=185&rft_id=info:doi/10.1002%2Fjcph.806&rft_id=info%3Apmid%2F27503249&rft_id=info%3Apmid%2F27503249&rft.externalDocID=27503249 |